Clinical trial Recruiting at 1 site Observational Ages 18 and up

Comparing non-invasive FFR‑CT with invasive FFR in a multi-ethnic hospital population

Official title: Correlation of Fractional Flow Reserve Computed Tomography (FFR CT) Findings With Invasive FFR in Coronary Artery Disease (CAD) in a Multi-ethnic Cohort- a Retrospective Study

Run by Sandwell & West Birmingham Hospitals NHS Trust · NCT06790836 · Data updated 2026-11-12

This project will test whether non-invasive FFR‑CT measurements match invasive FFR in adults with suspected coronary artery disease who had both tests.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment500 (estimated)
SponsorSandwell & West Birmingham Hospitals NHS Trust
Academic / other
Locations1 site (Birmingham, West Midlands)
StatusRecruiting
StartedMay 1, 2026
Main results expectedAugust 1, 2026
Study endsDecember 1, 2026
Registry record updatedMay 7, 2026
Trial IDNCT06790836 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for inclusion are adults (≥18 years) with stable chest pain treated at SWBH NHS Trust between 2019 and 2023 who had high-quality CTCA, FFR‑CT, and invasive FFR performed.

Probably not a fit

Patients who did not have all three tests, who have poor-quality or artifact-laden CT images, acute coronary syndromes, or who were not treated at the Trust during the specified period are unlikely to benefit from the study's findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a retrospective analysis of CT coronary angiography (CTCA) records from Sandwell and West Birmingham NHS Trust between January 2019 and December 2023, focusing on roughly 500 adults with stable chest pain who underwent CTCA, FFR‑CT, and invasive FFR. The clinical team will screen the database for eligible patients with high-quality CT images and extract paired FFR‑CT and invasive FFR results for comparison. Statistical correlation and diagnostic performance (sensitivity, specificity, predictive values) will be calculated overall and across ethnic groups to assess real-world accuracy. The goal is to clarify variability seen in prior observational work and inform whether FFR‑CT can reliably reduce invasive testing in routine practice.

Why it matters

Potential benefit: If results show good agreement, validated FFR‑CT could reduce the need for invasive testing, lowering procedure-related risk and healthcare costs for patients.

How similar studies have gone: Prior randomized and observational studies showed promising sensitivity and specificity for FFR‑CT but real-world observational series have reported variable predictive values, with some large cohorts showing a low positive predictive value.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* •≥18 years

  * Stable •patients with suspected CAD
  * Patients who underwent CTCA, FFR CT and had an invasive FFR.
  * CTCA images of high-quality for analysis, with clear visualisation of coronary arteries and minimal artifacts.

Exclusion Criteria:

* •\<18 years of age

  * Did not undergo FFR CT
  * Inadequate quality/degraded CTCA images

Where it's running

  • Sandwell and West Birmingham NHS Trust
    Birmingham, West Midlands, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.